Try our Advanced Search for more refined results
Health
-
March 04, 2026
Ill. Health System Can Take Privacy Case To 7th Circ.
An Illinois federal judge has refused to reconsider his decision to dismiss a privacy suit over tracking tools that purportedly share a health system's private patient information with Meta Platforms Inc., but he ruled the Chicago-area nonprofit can appeal to the Seventh Circuit.
-
March 04, 2026
Trump's FCA Expansion Plan Heightens Compliance Risk
In light of the Trump administration's record False Claims Act enforcement haul, companies should be especially mindful of a planned expansion in the scope of enforcement and the false compliance certification risks that may bring, attorneys say.
-
March 04, 2026
Regeneron, Sanofi Didn't Warn About Cancer Risk, Suit Says
Regeneron Pharmaceuticals and Sanofi-Aventis were sued Tuesday in Georgia federal court by a woman who said she experienced rapid progression of cutaneous T-cell lymphoma after getting injections of dupilumab, a medication the companies sell as Dupixent as a treatment for inflammation.
-
March 04, 2026
Doctor's Firing Dispute Belongs In Arbitration, Fla. Court Says
A Florida appeals court ruled Wednesday that a trial court erred in denying arbitration in a dispute between a women's healthcare clinic and its co-founder over his termination, finding the arbitration clauses in the employment agreements are not ambiguous.
-
March 04, 2026
9th Circ. Hesitant To Revive Implant Suit Against Medtronic
A Ninth Circuit panel cast doubt Wednesday on a Washington man's attempt to revive a negligence lawsuit against Medtronic for allegedly not assisting him when his spinal implant malfunctioned, hinting that his failure to find an expert witness to testify the device caused his pain may be fatal to the case.
-
March 04, 2026
5th Circ. Leery Of Tossing Doc's Conviction In $84M Scheme
A Fifth Circuit panel on Wednesday appeared skeptical that a doctor convicted of fleecing Medicare out of $84 million should get another shot at proving his innocence, pressing counsel for case law backing the doctor's stance that the lower court erred by excluding a defense witness.
-
March 04, 2026
DC Judge Strikes Down 340B Drug Discount Registration Rule
The U.S. Health Resources and Services Administration cannot reinstate a pre-pandemic policy requiring covered hospitals' offsite facilities to register with the agency in order to access discounted drugs under the 340B program, a D.C. federal judge ruled.
-
March 04, 2026
Fla. Hospital, EMT Beat Suit Over Unauthorized Trauma Photo
A Miami-area hospital and one of its emergency medical technicians didn't intentionally inflict emotional distress or violate the privacy of the father of a gravely injured motorcycle crash patient when an EMT posted a photo of the motorcyclist's injured leg to Instagram, a Florida appeals panel ruled Wednesday.
-
March 04, 2026
Select Medical's $3.9B Deal Is Latest Insider-Led Buyout
Select Medical Holdings Corp. will be taken private in a $3.9 billion deal led by its executive chair, another senior executive, and the private equity firm Welsh Carson Anderson & Stowe, marking the latest in a series of recent insider-led buyouts.
-
March 04, 2026
BakerHostetler Aided Illegal Insurance Scheme, Trustee Says
BakerHostetler, along with one of its Atlanta-based attorneys, is the latest law firm to be accused of legal malpractice related to an illegal scheme that sold health insurance-like products.
-
March 04, 2026
Sandoz Parent Targets Walmart, Southwest Generic Drug Suits
Sandoz parent company Sandoz AG contested generic drug price-fixing complaints from Southwest Airlines, Walmart, Walgreen and United Healthcare, arguing that the direct action plaintiffs cannot pursue the company in the wider Pennsylvania federal court multidistrict litigation because the Swiss firm is too far removed from its Sandoz Inc. subsidiary.
-
March 04, 2026
6th Circ. Backs Tenn. Med School In FMLA Retaliation Suit
A former medical resident cannot revive his lawsuit claiming a Tennessee medical school suspended him for taking leave under the Family and Medical Leave Act, the Sixth Circuit ruled this week, finding he failed to show the school's explanation for the discipline was a pretext for retaliation.
-
March 04, 2026
Buyers Finalize $58M Generic-Pricing Deal With 3 Drugmakers
Purchasers of certain generic drugs asked a Pennsylvania federal court for final approval of settlements worth a total of at least $58 million with Glenmark Pharmaceutical Inc., Greenstone LLC and Pfizer Inc. over claims the companies colluded with others to keep drug prices high.
-
March 04, 2026
NY Bill Would Expand Liability For Chatbot Operators
A bill in the New York State Senate that would impose liability on the owners and operators of artificial intelligence-powered chatbots that give advice reserved for licensed professionals like lawyers and doctors could reshape how some legal tech entities engage with consumers in the Empire State.
-
March 04, 2026
Judge Sets 'Hard Deadline' To Rule On Childhood Vax Policy
A Massachusetts federal judge said Wednesday he will rule within two weeks on a closely watched request to block the Centers for Disease Control and Prevention from paring back the recommended childhood vaccine schedule.
-
March 04, 2026
House Panel Tussles Over Minnesota Medicaid Fraud Claims
The public political battle between Minnesota and the federal government over alleged Medicaid fraud in the state continued Wednesday on Capitol Hill, with Republicans and Democrats casting stones at each other after President Donald Trump's administration pulled nearly $260 million in healthcare funding from the state.
-
March 04, 2026
7th. Circ. Upholds Healthcare Co.'s Win In FMLA Suit
The Seventh Circuit affirmed a healthcare company's win in a former human resources specialist's Family and Medical Leave Act suit, holding that the health system lawfully terminated her for failing to return to work once her approved leave expired.
-
March 04, 2026
Medical Pot Co. Can't Escape Guarantor Status In Lease Fight
A Puerto Rico federal judge won't let Vireo Health Inc. escape responsibility as guarantor of a lease under which one of its subsidiaries failed to pay a landlord, finding that it can't benefit from its own breach of the contractual terms.
-
March 04, 2026
Gordon Rees Opens New Offices In North Carolina, Wisconsin
Gordon Rees Scully Mansukhani has expanded its reach in the Southeast and Midwest by opening new offices in Charlotte, North Carolina, and Madison, Wisconsin.
-
March 03, 2026
11th Circ. Backs Dismissal Of Fee Dispute From BCBS MDL
The Eleventh Circuit has affirmed the dismissal of an attorney fee dispute between two lawyers on the plaintiffs' side of a $2.8 billion Blue Cross Blue Shield multidistrict litigation, ruling Tuesday that neither an oral deal nor a letter between the two lawyers was binding on their payouts.
-
March 03, 2026
Inova Defeats Nurses' COVID Vax Bias Suits At 4th Circ.
The Fourth Circuit refused Tuesday to revive suits from nurse anesthetists who said they faced religious and disability discrimination when they were fired for refusing to get vaccinated against COVID-19, ruling that nonprofit healthcare provider Inova wasn't their employer.
-
March 03, 2026
Death From Stem Cell Treatment For ALS Draws $24M Verdict
A Washington state jury awarded $24 million to the family of a patient who died just two days after what his family members described as a "worthless" spinal cord procedure to treat his ALS at a Seattle stem cell clinic.
-
March 03, 2026
Ex-FDA Leaders Rebut Contraception Rollbacks At 3rd Circ.
Former FDA commissioners argued that Trump-era religious exemptions for birth control coverage jeopardize public health and distort medical science, in an animus brief filed Monday with the Third Circuit.
-
March 03, 2026
FDA Targets Advertising For Knockoff Weight-Loss Meds
The U.S. Food and Drug Administration on Tuesday accused about 30 telehealth companies of illegally marketing compounded weight-loss and diabetes drugs, the agency's latest salvo in a crackdown on direct-to-consumer pharmaceutical advertising.
-
March 03, 2026
NC Doctor's Bid For New Trial Is Too Late, Judge Says
A North Carolina federal judge has refused to order a new trial for a doctor convicted of participating in an $11 million Medicare fraud scheme, finding that because the motion did not contain new evidence, the deadline to request another trial has passed.
Expert Analysis
-
What's At Stake In Possible Circuit Split On Medicaid Rule
A recent Eleventh Circuit decision, reviving Florida's lawsuit against a federal rule that reduces Medicaid funding based on agreements between hospitals, sets up a potential circuit split with the Fifth Circuit, with important ramifications for states looking to private administrators to run provider tax programs, say Liz Goodman, Karuna Seshasai and Rebecca Pitt at FTI Consulting.
-
Malpractice Claim Assignability Continues To Divide Courts
Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.
-
Courts' Rare Quash Of DOJ Subpoenas Has Lessons For Cos.
In a rare move, three federal courts recently quashed or partially quashed expansive U.S. Department of Justice administrative subpoenas issued to providers of gender-affirming care, demonstrating that courts will scrutinize purpose, cabin statutory authority and acknowledge the profound privacy burdens of overbroad government demands for sensitive records, say attorneys at ArentFox Schiff.
-
Unpacking Dormant Commerce Clause Cannabis Circuit Split
Federal courts have reached differing conclusions as to whether state-legal cannabis is subject to the dormant commerce clause, with four opinions across three circuit courts in the last year demonstrating the continued salience of the dormant commerce clause debate to the nation's cannabis industry, regulators and policymakers, say attorneys at Perkins Coie.
-
Remote Patient Monitoring Is At Regulatory Inflection Point
With remote patient monitoring at the center of new federal pilot programs and a recent report from the U.S. Department of Health and Human Services' Office of Inspector General examining Medicare billing for those services, it is clear that balancing innovation and risk will be a central challenge ahead for digital health stakeholders, say attorneys at Morgan Lewis.
-
Texas AG Wields Consumer Protection Law Against Tech Cos.
Texas Attorney General Ken Paxton has targeted technology companies using the Texas Deceptive Trade Practices Act, a broadly worded statute that gives the attorney general wide latitude to pursue claims beyond traditional consumer protection, creating unique litigation risks, say attorneys at Yetter Coleman.
-
Utah's AI Prescription Renewal Pilot Could Inform Policy
Utah recently became the first state to approve an artificial intelligence system for autonomously renewing certain prescription medicines, providing a test case for how regulators may be able to draw boundaries between administrative automation and medical judgment, say Jashaswi Ghosh at Holon Law Partners and Bryant Godfrey at Foley Hoag.
-
Ramped Up Psychedelic Production Carries Opportunity, Risk
Kimberly Chew at Husch Blackwell discusses the key legal implications of the U.S. Drug Enforcement Administration's recent dramatic increases in the production quotas for a range of psychedelic substances, offering guidance on compliance, risk management and strategic opportunities for practitioners navigating this rapidly evolving landscape.
-
Series
Teaching Logic Makes Me A Better Lawyer
Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.
-
New Biotech Nat'l Security Controls May Have Blunted Impact
While the newly enacted federal prohibition against contracting with certain biotechnology providers associated with countries of concern may have consequences on U.S. companies' ability to develop drugs, the restrictions may prove to be less problematic for the industry than the significant publicity around their passage would suggest, say attorneys at Wilson Sonsini.
-
Series
Law School's Missed Lessons: Practicing Resilience
Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.
-
Takeaways From The DOJ Fraud Section's 2025 Year In Review
Former acting Principal Deputy Chief Sean Tonolli of the U.S. Department of Justice's Fraud Section, now at Cahill Gordon, analyzes key findings from the section’s annual report — including the changes implemented to adapt to the new administration’s priorities — and lays out what to watch for this year.
-
4 Lessons From FTC's Successful Bid To Block Edwards Deal
The Federal Trade Commission's recent victory in blocking Edwards Lifesciences' acquisition of JenaValve offers key insights for deals in life sciences and beyond, including considerations around nonprice dimensions and clear skies provisions, say attorneys at Orrick.
-
Traditional FCA Enforcement Surges Amid Shifting Priorities
The U.S. Department of Justice’s January report on False Claims Act enforcement in fiscal year 2025 reveals that while the administration signaled its intent to expand FCA enforcement into new areas such as tariffs, for now the greatest exposure remains in traditional areas like healthcare — in which the risk is growing, say attorneys at Debevoise.
-
State Of Insurance: Q4 Notes From Illinois
In 2025's last quarter, Illinois’ appellate courts weighed in on overlapping homeowners coverages for water-related damages, contractual suit limitation provisions in uninsured motorist policies, and protections for genetic health information in life insurance underwriting, while the Department of Insurance sought nationwide homeowners' insurance data from State Farm, says Matthew Fortin at BatesCarey.